Zoetis (ZTS) Long-Term Deferred Tax (2012 - 2026)
Zoetis' (ZTS) quarterly Long-Term Deferred Tax came in at $617.0 million in Q2 2026, little changed year-over-year from $617.0 million in Q2 2025, and up 4.4% quarter-over-quarter from $591.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Long-Term Deferred Tax (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Long-Term Deferred Tax for 15 consecutive years, with $617.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Deferred Tax changed 0.0% year-over-year to $617.0 million in Q2 2026; TTM through Jun 2026 was $617.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $636.0 million, up 17.78% from the prior year.
- Long-Term Deferred Tax was $617.0 million for Q2 2026 at Zoetis, up from $591.0 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $636.0 million in Q4 2025 and troughed at $103.0 million in Q1 2022.
- A 5-year average of $353.9 million and a median of $299.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax jumped 162.14% in 2024 and changed 0.0% in 2026, its largest moves.
- Over 5 years, Long-Term Deferred Tax stood at $173.0 million in 2022, then gained by 19.08% to $206.0 million in 2023, then jumped by 162.14% to $540.0 million in 2024, then grew by 17.78% to $636.0 million in 2025, then dropped by 2.99% to $617.0 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $617.0 million (Q2 2026), $591.0 million (Q1 2026), and $636.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 617.00 Mn |
| Mar 31, 2026 | 591.00 Mn |
| Dec 31, 2025 | 636.00 Mn |
| Sep 30, 2025 | 587.00 Mn |
| Jun 30, 2025 | 617.00 Mn |
| Mar 31, 2025 | 530.00 Mn |
| Dec 31, 2024 | 540.00 Mn |
| Sep 30, 2024 | 409.00 Mn |
| Jun 30, 2024 | 366.00 Mn |
| Mar 31, 2024 | 232.00 Mn |
| Dec 31, 2023 | 206.00 Mn |
| Sep 30, 2023 | 190.00 Mn |
| Jun 30, 2023 | 192.00 Mn |
| Mar 31, 2023 | 161.00 Mn |
| Dec 31, 2022 | 173.00 Mn |
| Sep 30, 2022 | 111.00 Mn |
| Jun 30, 2022 | 110.00 Mn |
| Mar 31, 2022 | 103.00 Mn |
| Dec 31, 2021 | 100.00 Mn |
| Sep 30, 2021 | 110.00 Mn |